This inventor holds 2 USPTO granted patents. Top assignees: Betagene, Inc., The University of Texas System, Other. Active years: 2000-2001.
Company Filing History:
1 out of 4 
1 out of 5,630 
1 out of 834,411 Years Active: 2000-2001
Title: Philippe Halban: Innovator in Protein Expression Technologies
Introduction
Philippe Halban is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression. With a total of 2 patents, his work focuses on innovative methods for producing heterologous polypeptides.
Latest Patents
Halban's latest patents include groundbreaking methods for the recombinant expression of proteins from secretory cell lines. The first patent provides methods for the production of heterologous polypeptides using various recombinantly engineered secretory cell lines. A key feature of these cell lines is the absence of expression of at least one endogenous polypeptide. This allows the host cell machinery, typically used for producing the endogenous polypeptide, to be repurposed for the production of the heterologous polypeptide. The patent also describes methods for engineering cells for high-level expression, large-scale protein production, and treatment of diseases in vivo using viral delivery systems and recombinant cell lines. The second patent similarly focuses on the recombinant expression of proteins, specifically amylin, utilizing engineered cell lines. It outlines methods for high-level expression, large-scale heterologous protein production, and the isolation of novel amylin receptors.
Career Highlights
Throughout his career, Philippe Halban has worked with esteemed organizations such as the University of Texas System and Betagene, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Halban has collaborated with notable colleagues, including Christopher B. Newgard and Karl D. Normington. These partnerships have further enriched his research endeavors and innovations in the field.
Conclusion
Philippe Halban's contributions to protein expression technologies have positioned him as a key figure in biotechnology. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving methods for protein production.